Overcoming complexities to bring more metabolic disease treatments to market successfully
Metabolic diseases are a rising therapy area focus for clinical research due to high demand for novel therapies that are challenged with proving safety and efficacy. The development process is complicated and full of unknowns, and even the best metabolic therapeutic might not make it to the patients that need it, not because it does not work but because the design, data collection, and analysis were not done right.
At Atnahs Pharmaceuticals, we have assembled an extraordinary team of scientific-minded experts who have mastered the complexities of running metabolic disease trials. Our team has supported >180 projects for endocrine/metabolic disorder treatments and the preparation of 15 marketing applications – 13 of which have been approved so far!
